| Authors: |
Mousseaux E; Service de Radiologie, AP-HP, Hôpital Européen Georges-Pompidou, Université de Paris-Cité, 20-40 rue Leblanc, 75015 Paris, France.; Institut National de la Santé et de la Recherche Médicale, PARCC, Paris, France., Craiem D; Institut National de la Santé et de la Recherche Médicale, PARCC, Paris, France.; Instituto de Medicina Traslacional, Trasplante y Bioingeniería (IMeTTyB), Universidad Favaloro-CONICET, Buenos Aires, Argentina., Vliegenthart R; Department of Radiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Jacob S; Autorité de Sureté Nucléaire et de Radioprotection (ASNR), PSE-SANTE, SESANE, Laboratory of Epidemiology (LEPID), PSE-SANTE, SESANE, Fontenay-aux-Roses, France., Eraso A; Department of Radiation Oncology, Institut Català d'Oncologia, Barcelona, Spain., Constantino Rosa Santos S; Department of Radiation Oncology, Centro Cardiovascular da Universidade de Lisboa (CCUL@RISE), Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal., Borm K; School of Medicine and Health, Department of Radiation Oncology, Technical University of Munich, Munich, Germany., Langendijk JA; Partner Site Munich, Deutsches Konsortium für Translationale Krebsforschung (DKTK), Munich, Germany., Locquet M; Autorité de Sureté Nucléaire et de Radioprotection (ASNR), PSE-SANTE, SESANE, Laboratory of Epidemiology (LEPID), PSE-SANTE, SESANE, Fontenay-aux-Roses, France., Ventura M; Department of Radiation Oncology, Institut Català d'Oncologia, Barcelona, Spain., Fiúza M; Department of Radiation Oncology, Centro Cardiovascular da Universidade de Lisboa (CCUL@RISE), Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal., Combs SE; School of Medicine and Health, Department of Radiation Oncology, Technical University of Munich, Munich, Germany.; Partner Site Munich, Deutsches Konsortium für Translationale Krebsforschung (DKTK), Munich, Germany.; Department of Radiation Medicine (IRM), Helmholtz Zentrum München (HMGU), Neuherberg, Germany., Spoor DS; Partner Site Munich, Deutsches Konsortium für Translationale Krebsforschung (DKTK), Munich, Germany., Crijns APG; Partner Site Munich, Deutsches Konsortium für Translationale Krebsforschung (DKTK), Munich, Germany. |